<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62426">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02293239</url>
  </required_header>
  <id_info>
    <org_study_id>EMS Tumor 01</org_study_id>
    <nct_id>NCT02293239</nct_id>
  </id_info>
  <brief_title>Effects of WB-EMS and Dietetic Treatment on Cancer Patients</brief_title>
  <official_title>Effects of Whole Body Electromyostimulation (WB-EMS) and Dietetic Treatment on Patients With Malignant Disease in a Curative or Palliative Treatment Situation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-N端rnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-N端rnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effects of 12 weeks of whole body electrostimulation (WB-EMS) and
      dietetic treatment in patients with malignant disease on curative or palliative treatment
      situation on body composition, muscle strength and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2013</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lean Body Mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>Lean Body Mass (LBM) and Appendicular Skeletal Muscle Mass (ASMM) as assessed by Dual-Energy-xRay Absorptiometry (DXA) and bioelectrical impedance analysis (BIA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Isokinetic muscle strength</measure>
    <time_frame>12 weeks</time_frame>
    <description>Isokinetic muscle strength of the leg extensors and -flexors as assessed by isokinetic leg strength</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life (QoL)</measure>
    <time_frame>12 weeks</time_frame>
    <description>QoL as assessed by ECOG/WHO Performance Status, Karnofsky-Index and Depression Scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aerobic capacity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Aerobic capacity as assessed by 6 min walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory Markers</measure>
    <time_frame>12 weks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Electromyostimulation</condition>
  <condition>Malignant Disease</condition>
  <condition>Tumor Cachexia</condition>
  <condition>Dietetic Treatment</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>&quot;usual care&quot; with no physical or dietary intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WB-EMS with dietetic treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 min WB-EMS Training (2 per week)
+ dietetic treatment with protein-rich diet (protein &gt; 1,3 g/kg body weight)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole Body Electromyostimulation (WB-EMS), dietetic treatment</intervention_name>
    <arm_group_label>WB-EMS with dietetic treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  malignant disease: colon carcinoma, stomach cancer, oesophageal cancer, pancreas
             carcinoma, liver cell carcinoma, cholangiocarcinoma, bronchial carcinoma, mamma
             carcinoma, cervix cancer, prostate cancer, renal cell carcinoma, malignant melanoma,
             patients with leukaemia or Graft-versus-Host-Disease after bone marrow
             transplantation, tumour diseases of the cervical, pharyngeal or mouth area

          -  curative or palliative treatment situation

          -  men and women over, at least 18 years or older

        Exclusion Criteria:

          -  coincident participation in other interventional trials

          -  cardiovascular events

          -  use of medications with influence on muscular metabolism

          -  epilepsy

          -  severe neurological diseases

          -  skin lesions in the area of electrodes

          -  energy active metals in body
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medizinische Klinik 1, University of Erlangen-N端rnberg</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria / Franconia</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuradg端l Zopf, Prof. Dr. med.</last_name>
      <phone>0049 09131 8535225</phone>
      <email>yurdaguel.zopf@uk-erlangen.de</email>
    </contact>
    <contact_backup>
      <last_name>Hans Joachim Herrmann, Dr. oec. troph.</last_name>
      <phone>0049 09131 8545017</phone>
      <email>hans.herrmann@uk-erlangen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <lastchanged_date>November 13, 2014</lastchanged_date>
  <firstreceived_date>November 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>electromyostimulation</keyword>
  <keyword>cachexia</keyword>
  <keyword>cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cachexia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
